JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M204340200 on May 31, 2002

J. Biol. Chem., Vol. 277, Issue 32, 28934-28941, August 9, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/32/28934    most recent
M204340200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, A.
Right arrow Articles by Oshimi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, A.
Right arrow Articles by Oshimi, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ancient Ubiquitous Protein 1 Binds to the Conserved Membrane-proximal Sequence of the Cytoplasmic Tail of the Integrin alpha  Subunits That Plays a Crucial Role in the Inside-out Signaling of alpha IIbbeta 3*

Atsushi KatoDagger §, Norihiko KawamataDagger , Kenji TamayoseDagger , Motoki EgashiraDagger , Rika MiuraDagger , Tsutomu Fujimura, Kimie Murayama, and Kazuo OshimiDagger

From the Dagger  Division of Hematology, Department of Internal Medicine and  Division of Biochemical Analysis, Central Laboratory of Medical Sciences, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan

Received for publication, May 3, 2002, and in revised form, May 29, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Modification of the cytoplasmic tails of the integrin alpha IIbbeta 3 plays an important role in the signal transduction in platelets. We searched for proteins that bind to the alpha IIb cytoplasmic tail using the yeast two-hybrid assay with a cDNA library of the megakaryocyte-derived cell line and identified a protein, ancient ubiquitous protein 1 (Aup1), that is ubiquitously expressed in human cells. Observation of UT7/TPO cells expressing a red fluorescent protein-tagged Aup1 indicated its localization in the cytoplasm. Immunoprecipitation of UT7/TPO cells by an antibody for Aup1 revealed that ~40% of alpha IIb is complexed with Aup1. Binding study with an alpha IIb cytoplasmic tail peptide and glutathione S-transferase-Aup1 fusion protein revealed a low affinity (Kd = 90 µM). Subsequent yeast two-hybrid assay indicated binding of Aup1 to cytoplasmic tails of other integrin alpha  subunits. Binding study with the purified Aup1 and various glutathione S-transferase-alpha IIb cytoplasmic tail peptides revealed specific binding of Aup1 to the membrane-proximal sequence (KVGFFKR) that is conserved among the integrin alpha  subunits and plays a crucial role in the alpha IIbbeta 3 inside-out signaling. As Aup1 possesses domains related to signal transduction, these results suggest involvement of Aup1 in the integrin signaling.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Integrin alpha IIbbeta 3 (GPIIb-IIIa) is one of the receptors on the cellular surface of platelets and megakaryocytes. It binds to various adhesive proteins including fibrinogen, von Willebrand factor, vitronectin, and fibronectin that contain a core amino acid sequence of arginine-glycine-aspartic acids (RGD). Binding of fibrinogen to alpha IIbbeta 3 leads to platelet aggregation and finally to thrombus formation at the injured vascular sites. A pivotal role of alpha IIbbeta 3 in hemostasis is supported by the clinical observation that the congenital deficiency of alpha IIbbeta 3, Glanzmann's thrombasthenia, results in lifelong bleeding tendency (1). Whereas alpha IIbbeta 3 on resting platelets does not bind soluble fibrinogen, once platelets are activated, conformation of the extracellular domains of the alpha IIbbeta 3 is altered and its ligand-binding affinity is increased (affinity modulation) (2). This process of the inside-out signaling is considered to be mediated by modification of the short cytoplasmic tails of alpha IIb and beta 3 subunits; however, the mechanism remains to be elucidated.

The nuclear magnetic resonance structural analysis of the alpha IIb cytoplasmic tail revealed a closed conformation where the highly conserved N-terminal membrane-proximal region forms an alpha -helix followed by a turn, and the acidic C-terminal loop interacts with the N-terminal helix (3). Deletion of almost the entire alpha IIb-cytoplasmic tail and mutations in its N-terminal sequence (GFFKR) conserved among the integrin alpha  subunits enhance the affinity of alpha IIbbeta 3 for ligands (4-6). The cytoplasmic tail of the beta 3 subunit also has an amino acid sequence that is conserved among integrin beta  subunits: a stretch of 8 amino acids (KLLITIHD) adjacent to the transmembrane domain. In a similar fashion to the alpha IIb subunit, deletion or mutation in this conserved region induces activation of alpha IIbbeta 3 (6, 7). These observations suggest that membrane-proximal regions of the cytoplasmic domains of both subunits exert a negative regulatory function and lock alpha IIbbeta 3 in a low affinity state. Negative regulation may be mediated by the interaction between alpha IIb and beta 3 cytoplasmic tails, possibly through a salt bridge between Arg-995 in alpha IIb and Asp-723 in beta 3 (6), or binding of intracellular proteins to alpha IIb and/or beta 3 subunits. Two candidates for the modulator proteins have been reported: calcium- and integrin-binding protein (CIB)1 (8) and beta 3-endonexin (9, 10), which bind to alpha IIb and beta 3 cytoplasmic tails, respectively. Although CIB is unlikely to have a regulatory effect on alpha IIbbeta 3 ligand binding function (11), beta 3-endonexin fused to GST protein induces the conformational change of alpha IIbbeta 3 and activates it when co-transfected with alpha IIb and beta 3 subunits in Chinese hamster ovary cells. Another mechanism of modification has been recently suggested: an interaction between cytoplasmic tails of alpha IIbbeta 3 and the actin cytoskeleton. alpha IIbbeta 3 and the actin cytoskeleton are physically linked by binding of talin to the beta 3 cytoplasmic tail (12), and alpha IIbbeta 3 in resting platelets may be constrained in a low affinity state by the actin cytoskeleton (13). An increase in the cytosolic calcium evoked by agonist stimulation initiates actin filament turnover and may lead to relief of the cytoskeletal constraints on alpha IIbbeta 3, resulting in a high affinity state of alpha IIbbeta 3. Among these possible modification mechanisms, which one works in platelets remains to be determined.

In contrast, binding of fibrinogen to alpha IIbbeta 3 leads to platelet shape change, release of granules, and platelet aggregation. These sequential biological phenomena are mediated by the outside-in signaling of alpha IIbbeta 3, calcium mobilization, increase in the cytoplasmic pH, thromboxane A2 generation, and tyrosine phosphorylation of intracellular proteins including focal adhesion kinase and members of the Src family proteins (1). These signaling proteins are complexed with the actin cytoskeleton and are recruited to the focal contacts. In this process, the beta 3 cytoplasmic tail (residues 740-762) binds to the adaptor proteins Shc and Grb2 when tyrosine residues (Tyr-747 and Tyr-759) are phosphorylated (14). In addition, the beta 3 cytoplasmic tail is involved in clot retraction by transmitting the contractile force evoked by the rearrangement of the cytoskeletal proteins to the extracellular matrix (15). Thus, several proteins that bind to the beta 3 cytoplasmic tail and are implicated in the alpha IIbbeta 3 signaling have been identified; however , little is known about proteins that bind to and modify the alpha IIb cytoplasmic tail.

In this study, we searched for proteins that bind to the alpha IIb cytoplasmic tail in the thrombopoietin-dependent acute megakaryocytic leukemia-derived cell line, UT7/TPO (16), by the yeast-two hybrid assay and identified a protein, Aup1, that binds to the conserved membrane-proximal sequence of the cytoplasmic tail of the integrin alpha  subunits.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Lines-- UT7/TPO cell line (16) was maintained with Iscove's modified Dulbecco's medium supplemented with 20% fetal calf serum (FCS) and 10 ng/ml recombinant human thrombopoietin (TPO) (Kirin Brewery, Tokyo, Japan). Cell lines including HL 60, K562, U937, Jurkat, Raji, and CMK (17), established from acute myelocytic leukemia, chronic myelocytic leukemia, diffuse histiocytic lymphoma, T cell leukemia, Burkitt (B cell) lymphoma, and acute megakaryocytic leukemia, respectively, were maintained with RPMI medium supplemented with 10% FCS. Other cell lines including 293, MCF7, A549, HeLa, and HepG2, established from embryonic kidney, breast carcinoma, lung adenocarcinoma, epitheloid cervical carcinoma, and hepatocarcinoma, respectively, were maintained with Dulbecco's modified Eagle's medium supplemented with 10% FCS.

Amplification of the cDNA Sequence for the Cytoplasmic Domain of Integrin alpha  and beta  Subunits by PCR-- The cDNA sequences for the cytoplasmic domains of various integrin alpha  and beta  subunits were amplified by reverse transcription-PCR from RNA extracted from UT7/TPO for alpha IIb, alpha 2, alpha V, and beta 3, HepG2 for alpha 1, Raji for alpha 5, K562 for alpha M, and HL60 for beta 1 and beta 2, respectively. The cDNA sequences for a mutant alpha IIb (F992A) and for membrane-proximal (alpha IIb MP; KVGFFKR) and membrane-distal (alpha IIb MD; NRPPLEEDDEEGE) segments of the alpha IIb cytoplasmic tail were amplified using the normal alpha IIb cytoplasmic tail cDNA. The nucleotide sequence of each cDNA fragment amplified by PCR was confirmed using the ABI Prism dRhodamine terminator cycle sequencing ready reaction kit (Applied Biosystems Japan, Tokyo, Japan).

Yeast Two-hybrid Assays-- A cDNA library was constructed by ligating cDNA synthesized from UT7/TPO RNA to a pAD-Gal4 vector (Stratagene, La Jolla, CA). The cDNA sequence for the cytoplasmic domain of the integrin alpha IIb subunit was ligated in-frame to a pBD-Gal4 vector (Stratagene). Procedures for screening and the filter lift assay to confirm interactions between the bait and target proteins were according to the manufacturer's instructions. Briefly, yeast YRG-2 cells were transformed with a pAD-Gal4 plasmid encoding the UT7/TPO cDNA and a pBD-Gal4 plasmid encoding the alpha IIb bait. Then, yeast cells were plated on selective SD agar plates without leucine, tryptophan, and histidine (Leu- Trp- His-). Colonies grown on the selective plates, indicating interactions between target and bait proteins, were subjected to the filter lift assay to examine the beta -galactosidase activity to confirm the interaction. Positive yeast colonies were transferred to Whatman filter papers, frozen in the liquid nitrogen, thawed, and incubated with 5-bromo-4-chloro-3-indolyl-beta -D-galactoside (0.3 mg/ml) in Z buffer (per liter, 16.1 g of Na2HPO4/7H2O, 5.5 g of NaH2PO4/7H2O, 0.75 g of KCl, 0.246 g of MgSO4/7H2O, and 2.7 ml of 2-mercaptoethanol; pH 7.0). Colonies that produced blue color were picked up for the subsequent experiments. To examine interactions between the target protein and cytoplasmic tails of various integrin subunits including alpha IIb, alpha 1, alpha 2, alpha 5, alpha M, alpha V, beta 1, beta 2, and beta 3, yeast two-hybrid assays were performed in a similar fashion.

Quantitative beta -Galactosidase Assay-- To compare interactions between the target protein and the cytoplasmic domains of various integrin subunits, the quantitative beta -galactosidase assay (18) was performed. Briefly, yeast cells grown in 5 ml of medium at 30 °C until the near log phase (OD600 = ~1.0) were resuspended in Z buffer (200 µl) with glycerol (50 µl). After one cycle of freeze-thawing, 1 mM PMSF and acid-washed glass beads were added to the samples, followed by vigorous vortexing. Then, 50 µl of o-nitrophenyl-beta -D-galactoside (4 mg/ml, Sigma-Aldrich Japan, Tokyo, Japan) was added to the supernatants and the samples were incubated at 30 °C until a yellow color developed. After addition of 120 µl of Na2CO3 (1 M), the OD420 of each sample was measured. Assays were normalized to the yeast concentration (OD600) of each sample, and the beta -galactosidase activity was calculated as follows; beta -galactosidase units = 1,000 × OD420/t × V × OD600, where t = time of incubation in minutes, V = volume of culture added to Z buffer in ml (5 ml).

Northern Blot Analysis-- Approximately 30 µg of the total RNA extracted from UT7/TPO cells was electrophoresed in 1.5% agarose/formaldehyde gels, transferred to the nylon membranes (Hybond-N+, Amersham Biosciences, Buckinghamshire, United Kingdom), and hybridized with a full-length Aup1 cDNA fragment labeled with [alpha -32P]dCTP using a random-primed DNA labeling kit (Roche Molecular Biochemicals). To compare the expression of Aup1 transcripts among different human tissues, the Human 12-lane MTN Blot (CLONTECH Japan, Tokyo, Japan) was hybridized with the same probe.

Preparation of the Synthetic Peptides and Antibody Production-- Peptides for Aup1 (RLTPADKAEHMKRQRHPRLR) (Fig.1, A and B), alpha IIb and beta 3 cytoplasmic tails, to which a cysteine residue was added at the N terminus for the antibody production, were synthesized using PSSM-8 (Shimadzu, Kyoto, Japan). Each peptide was coupled to the keyhole limpet hemocyanin (Sigma-Aldrich) and injected subcutaneously to rabbits for immunization.

Immunoblot Analysis-- Platelets were isolated from the platelet-rich plasma of the normal peripheral blood, and leukocytes were isolated from the buffy coat after removal of erythrocytes by hypotonic lysis in 0.14 M NH4Cl, 20 mM Tris (pH 7.2) at 37 °C. Microscopic observation revealed that more than 90% of the prepared leukocytes were neutrophils. To extract proteins, platelets, leukocytes, UT7/TPO, and other cell lines including CMK, HL60, K562, U937, Jurkat, Raji, 293, HepG2, HeLa, MCF7, and A547 were resuspended in the cell lysis buffer (0.15 M NaCl, 10 mM Tris (pH 7.4), 1 mM PMSF, 1.8 µg/ml aprotinin, 100 µg/ml leupeptin, and 1% Triton X-100). Samples were incubated for 30 min on ice with occasional vortexing, and the cell lysates were subjected to 10% SDS-PAGE, transferred to the nitrocellulose membranes (Trans-blot transfer medium, Nippon Bio-Rad Laboratories, Yokohama, Japan). After blocking with 5% skimmed milk in Tris-buffered saline buffer (10 mM Tris (pH 7.4), 150 mM NaCl) for 1 h, membranes were incubated with a preimmune rabbit serum or the rabbit antiserum for the Aup1 peptide (Aup1-2) for 1 h, and then with the horseradish peroxidase-conjugated goat anti-rabbit immunoglobulins (DAKO Japan, Kyoto, Japan). Signals on membranes were detected with the ECL system (Amersham Biosciences).

Subcellular Localization of Aup1-- To study the subcellular localization of Aup1, a full-length Aup1 cDNA was ligated into the pDsRed1-N1 vector that encodes a red fluorescent protein (RFP) (CLONTECH). Then, UT7/TPO cells were transfected with a control vector and a plasmid encoding the Aup1-RFP fusion protein by electroporation using the Gene Pulser II (Bio-Rad). After selection with neomycin, stable cell lines that express RFP (UT7/TPO.VR4-4) and Aup1-RFP fusion proteins (UT7/TPO.Aup1 R23-1) were established. To examine the subcellular localization of Aup1, UT7/TPO.VR4-4 and UT7/TPO.Aup1R23-1 cells were applied to glass coverslips and observed using the LSM 510 laser scanning microscope (Carl Zeiss Microscopy, Jena, Germany) with appropriate filters. For the nuclear staining, cells were treated with 3.7% formaldehyde in phosphate-buffered saline and mounted with a medium containing 4',6'-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA).

Immunoprecipitation-- UT7/TPO cell extracts (600 µg of protein) with the cell lysis buffer containing 1% digitonin and 1 mM Ca2+ were incubated with a preimmune rabbit serum or the Aup1-2 antiserum (40 µl) for 1 h, and then with protein-G-Sepharose beads (30 µl) (Amersham Biosciences) for 3 h at 4 °C with gentle shaking. After washing with the cell lysis buffer, the beads were resuspended in the SDS sample buffer and boiled, and the supernatants were subjected to SDS-PAGE, followed by immunoblot analysis using mouse monoclonal antibodies for the alpha IIb (SZ22, Cosmo Bio, Tokyo, Japan) and beta 3 subunits (SZ21, Cosmo Bio). Signals were detected with the ECL system after incubation with the horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulins (DAKO). To measure how much part of the cellular alpha IIb is complexed with Aup1, the immunodepletion assay was performed. After preincubation with protein-G beads, UT7-TPO cell lysates (500 µg of protein) were immunoprecipitated twice with the control rabbit or the Aup1-2 serum (40 µl) and protein-G beads (50 µl). Then, aliquots of the supernatants (1-10 µl) were subjected to SDS-PAGE, followed by immunoblot analysis using the polyvinylidene difluoride (PVDF) membrane (Immobilon-P, Millipore, Bedford, MA) and the SZ22 antibody. Concentration of the residual (free) alpha IIb subunit was quantified by densitometry of the respective alpha IIb bands to calculate the percentage of alpha IIb bound to Aup1.

GST Pull-down Assay-- The cDNA sequences for Aup1, the normal and a mutant (F992A) alpha IIb cytoplasmic tails, and the membrane-proximal (alpha IIb MP) and membrane-distal segments (alpha IIb MD) were ligated in-frame to the pGEX-4T vector that encodes GST (Amersham Biosciences). For production of GST fusion proteins, DH5alpha cells transfected with the respective plasmids were incubated at 25 °C until the culture reached the mid-log phase (OD600 = ~0.8), at which time 25 µM isopropyl-beta -D-thiogalactopyranoside was added. After incubation for an additional 2 h, the bacteria were resuspended in phosphate-buffered saline containing 1 mM PMSF and 1 mg/ml lysozyme, followed by sonication. Triton X-100 was then added (1%), and the supernatant was incubated with the GSH-Sepharose beads (Amersham Biosciences) for 30 min at room temperature, followed by washing with phosphate-buffered saline. To examine association between Aup1 and cytoplasmic tails of alpha IIb and beta 3, beads that bound the GST-Aup1 fusion protein (125 µg) and the control GST protein (62.5 µg) were incubated with the UT7/TPO cell extract (1 mg of protein) in the GST reaction buffer (200 µl, the cell lysis buffer containing 1% Triton X-100) for 3 h at 4 °C with gentle shaking. Thereafter, beads were washed with the GST reaction buffer, resuspended in the SDS sample buffer, and boiled, and the supernatant was subjected to SDS-PAGE, followed by immunoblot analysis using the PVDF membrane, the rabbit antiserum for the cytoplasmic tails of alpha IIb and beta 3, and the horseradish peroxidase-conjugated goat anti-rabbit immunoglobulins. To identify the alpha IIb sequence to which Aup1 binds, Aup1 cleaved from the immobilized GST-Aup1 fusion protein by thrombin (Sigma-Aldrich) according to the manufacturer's instructions was preincubated with GSH- and GST-Sepharose beads in the GST reaction buffer. Then, the supernatants (50 µl containing 0.7 µg of Aup1; 0.4 µM) was incubated with the immobilized GST-alpha IIb cytoplasmic tail fusion proteins (20 µM), including the normal and a mutant (F992A) alpha IIb, alpha IIb MP, and alpha IIb MD segments, followed by SDS-PAGE and immunoblot analysis using the PVDF membrane and the Aup1-2 antiserum.

Estimation of the Affinity of Interaction between Aup1 and the alpha IIb Cytoplasmic Tail-- The synthetic alpha IIb cytoplasmic peptide was preincubated with the GST-Sepharose beads for 30 min at room temperature, and the supernatants (20-720 µM) were incubated with the immobilized GST-Aup1 fusion protein (1 µg, 1.5 µM) for 1 h at room temperature in the GST reaction buffer (10 µl). Then, various amounts of the supernatants, the original alpha IIb peptide, and the peptide preabsorbed by GST beads were subjected to 15% SDS-PAGE, followed by immunoblot analysis using the PVDF membrane and the rabbit antiserum for the alpha IIb cytoplasmic tail. The resulting immunoblots of the alpha IIb cytoplasmic tail were quantified by densitometry, and the affinity of Aup1 for binding to the alpha IIb cytoplasmic tail was calculated by Scatchard analysis (19).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of a Protein That Binds to the Integrin alpha IIb Cytoplasmic Tail-- To search for proteins that bind to the cytoplasmic tail of the integrin alpha IIb subunit, we constructed a cDNA library from a megakaryocyte-derived cell line, UT7/TPO. UT7/TPO cells constitutively express alpha IIbbeta 3 on the cellular surface, as confirmed by fluorescence-activated cell sorting analysis (data not shown). Screening of the cDNA library by the yeast two-hybrid assay with a bait of the alpha IIb cytoplasmic tail identified a 900-bp cDNA fragment that encodes a partial C-terminal peptide composed of 173 amino acids (48L21) (Fig. 1A). To obtain a cDNA sequence for the N-terminal portion, we performed PCR using UT7/TPO cDNA and primers from the 5'-terminal sequence of the cloning site of pAD-Gal4 (5'-AGGGATGTTTAATACCACTAC-3') and the 5'-terminal sequence of the 48L21 (5'-GCTGTTGTACACGGAGTGCA-3'). A 400-bp cDNA fragment (5'-48L21) was amplified, and the nucleotide sequencing revealed the sequence was continuous to the 5'-terminus of 48L21. For the final cloning of a full-length cDNA, PCR with UT7/TPO cDNA and primers from the 5'-terminal sequence of 5'-48L21 (5'-TGCGCCTGGGCGCGAAAATG-3') and 3'-terminal sequence of 48L21 (5'-GGCTCTGGGTGCCATCCTGT-3') was performed. Nucleotide sequencing of the amplified PCR product (1.3-kb cDNA fragment) revealed that the protein was composed of 410 amino acids. Subsequent data base searches indicated that the sequence was identical with the short isoform of Aup1 (Refs. 20 and 21; GenBankTM accession no. AF100753) (Fig. 1, A and B).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 1.   Amino acid sequence and a schematic representation of Aup1. A, the arrowhead indicates the position where 66 amino acids are inserted in the reported long isoform (Ref. 21; GenBankTM accession no. AF100754). The solid line indicates the amino acid sequence, against which the rabbit antiserum (Aup1-2) was raised. The broken line indicates the sequence encoded by 48L21 that was identified by the yeast two-hybrid assay. B, the shaded area and the arrowhead represent a putative signal sequence and a signal cleavage site, respectively. Aup1-2, the peptide used for antibody production; PlsC, phosphate acyltransferase domain; CUE, coupling of ubiquitin conjugation to the endoplasmic reticulum degradation domain.

Aup1 Is Ubiquitously Expressed in Human Cells and Tissues-- Northern blot analysis with the total RNA extracted from UT7/TPO cells using a full-length Aup1 cDNA probe revealed a transcript of ~1.7 kb (Fig. 2A). Because it was reported that Aup1 is expressed in all mouse tissues (20), we examined the expression of Aup1 transcripts in various human tissues. In concordance with the mouse tissues, Aup1 was expressed in all human tissues examined (Fig. 2B). To examine the expression of the Aup1 protein in UT7-TPO cells, platelets, leukocytes, and other cell lines, a rabbit antiserum was raised against a synthetic peptide for Aup1 (Fig. 1, A and B). Immunoblot analysis using this antiserum (Aup1-2) revealed duplicate bands of ~40 kDa at the reducing as well as non-reducing conditions in UT7/TPO cells (Fig. 3A). These bands were observed in other cell lines including CMK, HL60, K562, U937, Jurkat, Raji, HepG2, 293, HeLa, MCF7, and A547 (Fig. 3B). Treatment with the protein phosphatases did not change intensity of these two bands (data not shown). In contrast, only a smaller band was detected in platelets and leukocytes (Fig. 3C).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Expression of the Aup1 transcripts in human cells and tissues. A, total RNA of UT7/TPO cells was probed with a 32P-labeled Aup1 cDNA fragment. B, mRNA on the Human 12-lane MTN Blot (CLONTECH) was hybridized with the same probe; leukocytes (lane 1), lung (lane 2), placenta (lane 3), small intestine (lane 4), liver (lane 5), kidney (lane 6), spleen (lane 7), thymus (lane 8), colon (lane 9), skeletal muscle (lane 10), heart (lane 11), and brain (lane 12). Arrows indicate an Aup1 transcript (~1.7 kb), and the arrowhead (~2.1 kb) (B) may represent an alternatively spliced transcript. Molecular size markers are presented (28 and 18 S; ribosomal RNA, 2.4 and 1.35 (RNA size markers in kb)). beta 2MG, filters were reprobed with a 32P-labeled beta 2-microglobulin cDNA.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 3.   Expression of Aup1 protein in human cells. A, protein (150 µg) extracted from UT7/TPO cells were probed with a preimmune rabbit serum (lane 1), a rabbit antiserum for Aup1 (Aup1-2) (lane 2), and Aup1-2 with a synthetic Aup1 peptide (80 nM) (lane 3). Duplicate bands disappeared when an Aup1 peptide was added to the Aup1-2 antiserum, indicating that Aup1-2 recognizes the peptide sequence (lane 3). Protein size markers (kDa) are presented. B, protein extracts (150 µg) from human cell lines including 293 (lane 1), MCF7 (lane 2), A549 (lane 3), HeLa (lane 4), HepG2 (lane 5), Jurkat (lane 6), Raji (lane 7), U937 (lane 8), K562 (lane 9), HL 60 (lane 10), CMK (lane 11), and UT7/TPO (lane 12) were probed with Aup1-2. beta -actin; filters were reprobed with an anti-beta actin antibody (Sigma). C, protein extracts from UT7/TPO cells (150 µg, lanes 1 and 2), platelets (100 µg, lanes 3 and 4), and leukocytes (125 µg, lanes 5 and 6) were probed with a preimmune rabbit serum (lanes 1, 3, and 5) and Aup1-2 (lanes 2, 4, and 6). Arrowheads indicate Aup1. Although duplicate bands of ~40 kDa were observed in cell lines, only a smaller band was detected in platelets and leukocytes.

Aup1 Is Present in Cytoplasm-- To examine the subcellular localization of Aup1, stable UT7/TPO cell lines that express the Aup1-RFP fusion protein (UT7/TPO.Aup1R23-1) and the control RFP (UT7/TPO.VR4-4) were established. Overexpression of Aup1 did not affect the expression of alpha IIbbeta 3 on the cellular surface, as confirmed by fluorescence-activated cell sorting analysis of UT7/TPO, UT7/TPO.VR4-4, and UT7/TPO.Aup1R23-1 cells (data not shown). Observation of UT7/TPO.VR4-4 and UT7/TPO.Aup1 R23-1 cells by confocal microscopy revealed that RFP was distributed evenly throughout the cell; however, the Aup1-RFP fusion protein was observed in the cytoplasm, but not in the nucleus (Fig. 4). Because it was reported that the N terminus of mouse Aup1 resembles the signal peptide of secreted protein, followed by a putative signal cleavage site, we examined whether Aup1 is secreted from cells. Immunoblot analysis with the culture supernatant of UT7/TPO cells using the Aup1-2 antiserum revealed that Aup1 could not be detected in the concentrated (10-fold) culture supernatant (data not shown). These results indicate that Aup1 is a cytoplasmic protein.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 4.   Subcellular localization of Aup1. Confocal microscopy of the stable UT7/TPO cell lines expressing an RFP (UT7/TPO.VR4-4) (a and c) and an Aup1-RFP fusion protein (UT7/TPO.Aup1R23-1) (b and d). Nucleus was stained by 4',6'-diamidino-2-phenylindole (c and d). Although RFP is distributed evenly throughout the cell (a and c), the Aup1-RFP fusion protein was observed in the cytoplasm without localization in the nucleus (b and d). White bars represent 10 µm.

Approximately 40% of the alpha IIb Subunit Is Complexed with Aup1 in UT7/TPO Cells-- To examine whether Aup1 is associated with the alpha IIb cytoplasmic tail in the eukaryotic cells, UT7-TPO cell lysate was immunoprecipitated with the Aup1-2 antiserum. Immunoblot analysis with the precipitates using anti-alpha IIb and -beta 3 antibodies indicated that Aup1 bound to the alpha IIb, but not to the beta 3 subunit (Fig. 5A). We then measured how much of the cellular alpha IIb subunit is complexed with Aup1 by the immunodepletion assay. Densitometric analysis of the resulting alpha IIb bands with the supernatants of the UT7-TPO cell lysate after immunoprecipitation with the Aup1-2 and the control rabbit serum revealed that 41.7 ± 3.2% (mean ± S.D., results from three independent experiments) of the alpha IIb subunit was complexed with Aup1 (data not shown). Binding of Aup1 to the alpha IIb cytoplasmic tail was confirmed by the GST pull-down assay, revealing that GST-tagged Aup1 binds to the alpha IIb, but not to the beta 3 subunit (Fig. 5B).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 5.   Interaction between Aup1 and the cytoplasmic tail of the integrin alpha IIb subunit. A, immunoprecipitation. UT7/TPO cell lysate (600 µg of protein) coprecipitated with a preimmune rabbit serum (lanes 1-3) and an antiserum for Aup1 (Aup1-2) (lanes 4-6), and the control lysate (30 µg, lanes 7-9) were probed with the control mouse immunoglobulin (lanes 1, 4, and 7), the mouse monoclonal antibodies for alpha IIb (SZ22) (lanes 2, 5, and 8) and beta 3 (SZ21) subunits (lanes 3, 6, and 9). Arrowheads indicate the alpha IIb subunit. Filters (lanes 4-6) were reprobed with the antiserum for Aup1 (Aup1-2) (strips below lanes 4-6). B, GST pull-down assay. Control GST protein (lanes 1-3) and the GST-Aup1 fusion protein (lanes 4-7) that bound to GSH-Sepharose beads were incubated with UT7/TPO cell lysates. These samples (lanes 1-7) and the UT7/TPO cell lysate (100 µg of protein, lanes 8-10) were probed with a preimmune rabbit serum (lanes 1, 4, and 8), rabbit antiserum against alpha IIb (lanes 2, 5, and 9) and beta 3 cytoplasmic tails (lanes 3, 7, and 10). To examine competition, the alpha IIb cytoplasmic tail peptide (0.8 µM) was added to the antiserum against the same peptide (lane 6). Arrowheads indicate alpha IIb subunits. Strips were reprobed with the goat antiserum for GST (Amersham Biosciences); GST (strips below lanes 1-3) and GST-Aup1 fusion protein (strips below lanes 4-7).

Aup1 Interacts with the alpha IIb Cytoplasmic Tail with a Low Affinity-- We next studied interaction between the synthetic peptide for the alpha IIb cytoplasmic tail and immobilized GST-Aup1 fusion protein to measure the affinity of interaction. The Kd value calculated from the Scatchard plot analysis was 90 µM, suggesting a relatively weak affinity of interaction between Aup1 and the alpha IIb cytoplasmic tail (Fig. 6).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 6.   Estimation of the affinity of interaction between Aup1 and the alpha IIb cytoplasmic tail. A, various amounts of the synthetic peptide for the alpha IIb cytoplasmic tail were incubated with the immobilized GST-Aup1 fusion protein, followed by SDS-PAGE and immunoblot analysis with the antiserum for the alpha IIb cytoplasmic tail. The amounts of the alpha IIb peptide bound to Aup1 were quantified by densitometry. B, Scatchard plot of the same data was linear, giving Kd value of 90 µM.

Aup1 Binds to Cytoplasmic Tails of Various Integrin alpha  Subunits-- As Aup1 is expressed ubiquitously in human cells and tissues, we examined whether Aup1 binds to cytoplasmic tails of other integrin alpha  as well as beta  subunits by the yeast two-hybrid assays. Yeast cells were co-transformed with plasmids encoding Aup1 (48L21) and cytoplasmic tails of alpha IIb, alpha 1, alpha 2, alpha 5, alpha V, alpha M, beta 1, beta 2, and beta 3. In selective Leu- Trp- His- plates, only colonies co-transformed with Aup1 and alpha  subunits grew. These colonies were positive for both of the filter lift assay and the quantitative beta -galactosidase assay (Fig. 7). These results indicate that Aup1 binds to cytoplasmic tails of various integrin alpha  subunits.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 7.   Quantitative beta -galactosidase assay indicating associations between Aup1 and cytoplasmic tails of the integrin alpha  subunits. Interactions between Aup1 and cytoplasmic tails of various integrin alpha  and beta  subunits in the yeast two-hybrid assay are presented as activity of beta -galactosidase. Yeast cells transfected with Aup1 (Aup1), Aup1 with the control pBD-Gal4 vector (pBD), Aup1 with alpha  subunits (alpha IIb, alpha 1, alpha 2, alpha 5, alpha V, and alpha M), and Aup1 with beta  subunits (beta 1, beta 2, and beta 3), were grown in Leu-, Leu- Trp-, Leu- Trp- His-, and Leu- Trp- selective medium, respectively. Bars represent the mean ± S.D. of three separate experiments, each performed on five independent colonies.

Aup1 Binds to the Conserved Membrane-proximal Sequence of the Cytoplasmic Tail of the Integrin alpha  Subunits-- The amino acid sequence of the membrane-proximal region of the cytoplasmic tail is highly conserved among the integrin alpha  subunits and plays a crucial role in the inside-out signaling of alpha IIbbeta 3 (4-6). As the results from the yeast two-hybrid assay suggested binding of Aup1 to this conserved sequence, we examined interaction between the purified Aup1 and immobilized GST fusion proteins of the alpha IIb cytoplasmic tail, including the normal and a mutant (F992A) alpha IIb that leads to the high affinity state of alpha IIbbeta 3 (6), and the membrane-proximal (KVGFFKR) and membrane-distal (NRPPLEEDDEEGE) sequences. The GST pull-down assay revealed binding of Aup1 to the normal and the membrane-proximal alpha IIb sequence, but neither to the mutant nor to the membrane-distal sequence (Fig. 8). These results indicate that Aup1 binds to the specific short amino acid stretch that is located at the membrane-proximal region and conserved among the cytoplasmic tails of the integrin alpha  subunits.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 8.   Interaction between Aup1 and GST-alpha IIb cytoplasmic tail fusion proteins. 50 ng of the purified Aup1 (lane 1) and 0.7 µg (0.4 µM) incubated with the immobilized GST fusion proteins (20 µM) of the alpha IIb cytoplasmic tail, including the normal alpha IIb (lane 2), membrane-proximal sequence (KVGFFKR) (lane 3), membrane-distal sequence (NRPPLEEDDEEGE) (lane 4), and a mutant alpha IIb (F992A) (lane 5), were subjected to immunoblot analysis using antiserum for Aup1 (Aup1-2). Arrowheads represent Aup1 and thick bands at the bottom of lanes 2-5 represent respective GST-alpha IIb cytoplasmic peptide fusion proteins.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

One of the obstacles to elucidate the integrin alpha IIbbeta 3 signaling is the absence of appropriate cell lines that exhibit similar properties to platelets including expression of alpha IIbbeta 3 and intracellular signaling molecules, and the response to platelet physiological agonists. Because the alpha IIb subunit is exclusively expressed in platelets and megakaryocytes, it is suggested that a megakaryocyte-derived cell line would be suitable to search for proteins that bind to the alpha IIb cytoplasmic tail. In this study, we performed the yeast two-hybrid assay and screened the cDNA library from UT7/TPO cells using the alpha IIb cytoplasmic tail as bait. Binding of Aup1 to the alpha IIb cytoplasmic tail was demonstrated by the following results. First, Aup1 bound to the alpha IIb cytoplasmic tail in the yeast two-hybrid assay. Second, Aup1 is a cytoplasmic protein, as indicated by the observation with the confocal microscopy of UT7/TPO cells that express an RFP-tagged Aup1. Third, the alpha IIb subunit was present in the immunoprecipitate of the UT7-TPO cell lysate by the antiserum for Aup1. Fourth, GST-tagged Aup1 bound to the alpha IIb subunit in the UT7-TPO cells.

The N terminus of Aup1 is hydrophobic and resembles the signal sequence of secreted proteins, followed by an 11-amino acid sequence with similarity to a prokaryotic lipid attachment site (20) (Fig. 1B). These characteristic amino acid sequences and the present observations with confocal microscopy and immunoblot analysis with the culture supernatant of UT7/TPO cells suggest that Aup1 is a cytoplasmic protein in possible association with the plasma membrane. Immunoblot analysis with the antiserum for an Aup1 peptide revealed duplicate bands of ~40 kDa with an estimated molecular mass difference of ~3-4 kDa in UT7/TPO and other cell lines. In contrast, only a smaller band was detected in platelets and leukocytes. Although only a single cDNA fragment encoding 410 amino acids was amplified by PCR with UT7/TPO cDNA in the present study, a long isoform of Aup1 composed of 476 amino acids has been reported to be produced by alternative splicing of the Aup1 gene (21). However, considering the difference in the number of amino acids (66) between these two isoforms, it is unlikely that duplicate bands observed in the immunoblot analysis are produced by alternative splicing. Another possible examination is the posttranslational modification including glycosylation, phosphorylation, and cleavage. As the consensus amino acid sequences for the O- and N-linked glycosylation sites are absent in Aup1 and only a smaller band is observed in terminally differentiated platelets and leukocytes, it is hard to explain that the larger protein represents a glycosylated mature protein. With regard to phosphorylation, tyrosine, serine, and/or threonine residues are phosphorylated upon cellular stimulation as observed in a number of intracellular signaling proteins. However, modification by phosphorylation is unlikely because duplicate bands were constitutively expressed and did not exhibit any difference in their intensity after treatment with the protein phosphatase in the immunoblot analysis. On the other hand, the difference in the estimated molecular mass of these two bands (~3-4 kDa) is concordant with that of the postulated signal sequence composed of 37 amino acids. Accordingly, it is conceivable that a larger band represents a precursor protein subjected to cleavage to the smaller mature protein, followed by possible modification with lipid attachment including myristoylation, prenylation, and/or palmitoylation to be associated with the internal leaflet of the plasma membrane (22).

It was reported that mouse Aup1 also consists of 410 amino acids and is expressed in all mouse tissues. In addition, it exhibits an amino acid sequence similar to those of Caenorhabditis elegans and human Aup1 (20). Because of its evolutionary conservation of the amino acid sequence and ubiquitous expression, it appears that Aup1 plays an essential role in cell biology. It was unexpected that Aup1, a ubiquitously expressed protein in various tissues, binds to the cytoplasmic tail of the alpha IIb subunit that is exclusively expressed in platelets and megakaryocytes. Accordingly, we examined whether Aup1 binds to the cytoplasmic tails of other integrin alpha  as well as beta  subunits. The yeast two-hybrid assays revealed that Aup1 binds to the cytoplasmic tails of the alpha 1, alpha 2, alpha 5, alpha M, and alpha V subunits, but not to the beta 1, beta 2, and beta 3 subunits, indicating specific binding of Aup1 to the integrin alpha  subunits. To confirm association between Aup1 and these alpha  subunits, we performed immunoprecipitation using cell lines that express a relatively high level of these alpha  subunits, including IMR32 treated by retinoic acid for alpha 1, CCRF-CEM for alpha 2, HeLa treated by IL-6 for alpha 5, K562 for alpha M, and RAW264.7 for alpha V. However, we could co-precipitate Aup1 with these integrin alpha  subunits neither by the Aup1-2 nor by various antiserum for these subunits, probably because the expression level of these proteins is extremely low compared with the alpha IIb subunit in UT7/TPO cells (data not shown). On the other hand, subsequent GST pull-down assay indicated binding of Aup1 to the membrane-proximal amino acid sequence (KVGFFKR) that is conserved among the cytoplasmic tails of the integrin alpha  subunits. Accordingly, it seems that one of the essential biological functions of Aup1 is to bind to the cytoplasmic tail of the integrin alpha  subunits through the conserved membrane-proximal sequence.

A data base search for the homologous domain structure revealed that Aup1 possesses two domains: CUE and PlsC domains (23). The yeast protein Cue1p is a prototype of CUE domain family and belongs to the integral endoplasmic reticulum membrane proteins. It exhibits a scaffolding activity and recruits the ubiquitin-conjugating enzymes Ubc7p and Ubc6p in the proximity of the translocon pore cytoplasmic exit to deliver proteins for ubiquitination and subsequent digestion by the proteasome (24). The CUE domain is also present in several eukaryotic cytoplasmic proteins. It was suggested that some of the CUE-containing proteins are not associated with endoplasmic reticulum and possess functions different from that of Cue1p (23). Recent studies identified two eukaryote proteins with the CUE domain, Toll-interacting protein (Tollip) and transforming growth factor beta -activated kinase1 (TAK1)-binding protein 2 (TAB2), that exhibit novel functions in the IL-1 signal transduction pathway. Tollip is present in a complex with the serine/threonine IL-1 receptor (IL-1R)-associated kinase (IRAK) and binding of IL-1 to IL-1R results in the rapid assembly of a membrane-proximal signaling complex that consists of IL-1R, an adaptor protein (myeloid differentiation protein; MyD88), IRAK, and Tollip. Because overexpression of Tollip results in impaired IL-1beta -induced activation of the nuclear transcription factor kappa B and c-Jun N-terminal kinase, it may inhibit IL-1 signaling by silencing components of the signaling cascade including IRAK (25). TAB2 is an adaptor protein that mediates activation of TAK1. IL-1 stimulates translocation of TAB2 from the membrane to the cytosol where it mediates association of TAK1 with the tumor necrosis factor receptor-associated factor 6 (TRAF6), leading to activation of TAK1 (26).

In addition to possessing the CUE domain, the amino acid sequence of Aup1 exhibits a significant similarity to taffazins that belong to the acyltransferase superfamily (27, 28), suggesting that Aup1 may exhibit an enzymatic activity. Taffazins are composed of a highly hydrophobic N terminus of 30 amino acids that may serve a membrane anchor and a central hydrophilic domain composed of 72 residues that may serve as an exposed loop interacting with other proteins. Mutations of a gene encoding taffazins (G4.5) lead to a severe inherited (X-linked) disorder, Barth syndrome, that is characterized by cardiac and skeletal myopathy, short stature, and neutropenia, indicating an essential biological function of taffazins (29). Acyltransferases of the tafazzin superfamily all function in phospholipid synthesis and have either glycerophosphate (GPAT, EC 2.3.15), 1-acylglycerophosphate (AGPAT, EC2.3.1.51), 2-acylglycerophosphate, or 2-acylglycerophosphoethanolamine acyltransferase activity (28). The initial step of phospholipid biosynthesis involves the acylation of glycerol-3-phosphate by GPAT to form lysophosphatidic acid (LPA), followed by acylation of LPA by AGPAT to form phosphatidic acid (PA). In addition to being the key intermediates in the phospholipid biosynthesis, PA and LPA are the essential lipid messengers in signal transduction. Thrombin stimulation leads to production of LPA, followed by its extracellular release in platelets. Binding of LPA to its G protein-coupled receptor leads to stimulation of phospholipases C and D, inhibition of adenylyl cyclase, activation of Ras and the downstream Raf/mitogen-activated protein kinase pathway, and tyrosine phosphorylation of focal adhesion proteins accompanied by remodeling of the actin cytoskeleton in the integrin signaling pathway (30). In contrast, PA can act as an intracellular as well as an extracellular messenger, activating phospholipase C and the numerous protein kinases involved in the signal transduction of the protein kinase C and Raf/mitogen-activated protein kinase pathways (31, 32). Moreover, fibrinogen binding to alpha IIbbeta 3 incorporated into PA-containing lipid vesicles is enhanced, indicating that PA can modulate affinity of alpha IIbbeta 3 within a membrane environment (33). Implications in signal transduction have also been reported both with GPAT and AGPAT; insulin and epidermal growth factor activate GPAT and increase de novo PA synthesis, which may amplify diacylglycerol-protein kinase C signaling (34). Stimulation with IL-1beta increases AGPAT activity and leads to an enhanced transcription and synthesis of tumor necrosis factor-alpha and IL-6, suggesting AGPAT may amplify cellular signaling responses from cytokines (32).

Taken together, it is conceivable that Aup1 is involved in the integrin signaling. Binding of Aup1 to the cytoplasmic tail of the integrin alpha  subunits may alter interactions between alpha  and beta  cytoplasmic tails, including interference of the salt bridge formation as predicted between Arg-995 in alpha IIb and Asp-723 in beta 3. Otherwise, Aup1 may function as an adaptor protein by its CUE domain and recruit signaling molecules to integrin cytoplasmic tails, or exert a phosphate acyltransferase activity by its PlsC domain, leading to alternation in the local concentrations of PA and LPA. Consequently, conformation of the integrin extracellular domains may be altered (inside-out signaling), or the sequential biological phenomenon evoked by ligand binding may be modulated (outside-in signaling). The GST pull-down assay indicated binding of Aup1 to the conserved membrane-proximal sequence of the integrin alpha  subunits. As deletions or mutations in this region lead to an increase in the affinity of alpha IIbbeta 3 for ligands (4-6) and a mutation in this region (F992A) prevents binding of Aup1, it is conceivable that binding of Aup1 to this sequence may sustain integrin in a low affinity state. In the inside-out signaling of platelets, thrombin stimulation leads to the rapid activation of tyrosine kinases, including Syk, which is activated within seconds (35), and Src family kinases, and tyrosine phosphorylation of the signaling proteins (36). Considering the remarkable rapidity of this signaling process, Aup1 which binds to the alpha IIb cytoplasmic tail reversibly as suggested by the relatively low affinity of interaction, may be suitable for one of the modulators in the alpha IIbbeta 3 inside-out signaling. However, further studies are necessary to elucidate implication of Aup1 in the integrin signaling and other biological functions.

    ACKNOWLEDGEMENT

We are grateful to Dr. N. Komatsu for providing UT7/TPO cells.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 81-3-3813-3111; Fax: 81-3-3813-0841; E-mail: atkato@med.juntendo.ac.jp.

Published, JBC Papers in Press, May 31, 2002, DOI 10.1074/jbc.M204340200

    ABBREVIATIONS

The abbreviations used are: CIB, calcium- and integrin-binding protein; Aup1, ancient ubiquitous protein 1; GST, glutathione S-transferase; CUE, coupling of ubiquitin conjugation to the endoplasmic reticulum degradation; PlsC, phosphate acyltransferase; TPO, thrombopoietin; RFP, red fluorescent protein; Tollip, Toll-interacting protein; TAK1, transforming growth factor beta -activated kinase 1; TAB2, transforming growth factor beta -activated kinase 1-binding protein 2; IL, interleukin; IL-1R, interleukin-1 receptor; IRAK, interleukin-1 receptor-associated kinase; GPAT, glycerophosphate acyltransferase; AGPAT, 1-acylglycerophosphate acyltransferase; LPA, lysophosphatidic acid; PA, phosphatidic acid; FCS, fetal calf serum; PMSF, phenylmethylsulfonyl fluoride; PVDF, polyvinylidene difluoride; MD, membrane-distal; MP, membrane-proximal.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Kato, A. (1997) Crit. Rev. Oncol./Hematol. 26, 1-23[Medline] [Order article via Infotrieve]
2. Smyth, S. S., Joneckis, C. C., and Parise, L. V. (1993) Blood 81, 2827-2843[Free Full Text]
3. Vinogradova, O., Haas, T., Plow, E. F., and Qin, J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 1450-1455[Abstract/Free Full Text]
4. O'Toole, T. E., Mandelman, D., Forsyth, J., Shattil, S. J., Plow, E. F., and Ginsberg, M. H. (1991) Science 254, 845-847[Abstract/Free Full Text]
5. O'Toole, T. E., Katagiri, Y., Faull, R. J., Peter, K., Tamura, R., Quaranta, V., Loftus, J. C., Shattil, S. J., and Ginsberg, M. H. (1994) J. Cell Biol. 124, 1047-1059[Abstract/Free Full Text]
6. Hughes, P. E., Diaz-Gonzalez, F., Leong, L., Wu, C., McDonald, J. A., Shattil, S. J., and Ginsberg, M. H. (1996) J. Biol. Chem. 271, 6571-6574[Abstract/Free Full Text]
7. Hughes, P. E., O'Toole, T. E., Ylanne, J., Shattil, S. J., and Ginsberg, M. H. (1995) J. Biol. Chem. 270, 12411-12417[Abstract/Free Full Text]
8. Naik, U. P., Patel, P. M., and Paraise, L. V. (1997) J. Biol. Chem. 272, 4651-4654[Abstract/Free Full Text]
9. Shattil, S. J., O'Toole, T., Eigenthaler, M., Thon, V., Williams, M., Babior, B. M., and Ginsberg, M. H. (1995) J. Cell Biol. 131, 807-816[Abstract/Free Full Text]
10. Kashiwagi, H., Schwartz, M. A., Eigenthaler, M., Davis, K. A., Ginsberg, M. H., and Shattil, S. J. (1997) J. Cell Biol. 137, 1433-1443[Abstract/Free Full Text]
11. Vallar, L., Melchior, C., Plançon, S., Drobecq, H., Lippens, G., Regnault, V., and Kieffer, N. (1999) J. Biol. Chem. 274, 17257-17266[Abstract/Free Full Text]
12. Calderwood, D. A., Zent, R., Grant, R., Rees, D. J., Hynes, R. O., and Ginsberg, M. H. (1999) J. Biol. Chem. 274, 28071-28077[Abstract/Free Full Text]
13. Bennett, J. S., Zigmond, S., Vilaire, G., Cunningham, M. E., and Bednar, B. (1999) J. Biol. Chem. 274, 25301-25307[Abstract/Free Full Text]
14. Law, D. A., Nannizzi-Alaimo, L., and Phillips, D. R. (1996) J. Biol. Chem. 271, 10811-10815[Abstract/Free Full Text]
15. Chen, Y.-P., O'Toole, T. E., Leong, L., Liu, B.-Q., Diaz-Gonzalez, F., and Ginsberg, M. H. (1995) Blood 86, 2606-2615[Abstract/Free Full Text]
16. Komatsu, N., Kunitama, M., Hagiwara, T., Kato, T., Miyazaki, H., Eguchi, M., Yamamoto, M., and Miura, Y. (1996) Blood 87, 4552-4560[Abstract/Free Full Text]
17. Sato, T., Fuse, A., Eguchi, M., Hayashi, Y., Ryo, R., Adachi, M., Kishimoto, Y., Teramura, M., Mizoguchi, H., Shima, Y., Komori, I., Sunami, S., Okimoto, Y., a